Literature DB >> 20944782

Osmotic release oral system (OROS) Methylphenidate-induced double incontinence: a case report.

Ching-Shu Tang1, Wen-Jiun Chou, Andrew T A Cheng.   

Abstract

Entities:  

Year:  2010        PMID： 20944782      PMCID： PMC2947529          DOI： 10.4088/PCC.09l00870pur

Source DB:  PubMed          Journal:  Prim Care Companion J Clin Psychiatry        ISSN： 1523-5998


× No keyword cloud information.
  11 in total

1.  A case report of olanzapine-induced fecal incontinence.

Authors:  D N Mendhekar; P K Srivastav; S K Sarin; R C Jiloha
Journal:  J Clin Psychiatry       Date:  2003-03       Impact factor: 4.384

Review 2.  The worldwide prevalence of ADHD: a systematic review and metaregression analysis.

Authors:  Guilherme Polanczyk; Maurício Silva de Lima; Bernardo Lessa Horta; Joseph Biederman; Luis Augusto Rohde
Journal:  Am J Psychiatry       Date:  2007-06       Impact factor: 18.112

3.  Pathogenesis and pathophysiology of attention-deficit/hyperactivity disorder: from childhood to adulthood.

Authors:  M Gerlach; J Deckert; A Rothenberger; A Warnke
Journal:  J Neural Transm (Vienna)       Date:  2008       Impact factor: 3.575

4.  Effect of extended release stimulant-based medications on neuropsychological functioning among adolescents with Attention-Deficit/Hyperactivity Disorder.

Authors:  H Kent Wilson; Daniel J Cox; R Lawrence Merkel; Melissa Moore; David Coghill
Journal:  Arch Clin Neuropsychol       Date:  2006-10-17       Impact factor: 2.813

5.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

Review 6.  Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder.

Authors:  J Biederman; T Spencer
Journal:  Biol Psychiatry       Date:  1999-11-01       Impact factor: 13.382

Review 7.  Pharmacotherapy of attention deficit hyperactivity disorder.

Authors:  T Spencer; J Biederman; T Wilens
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2000-01

8.  Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment.

Authors:  J M Swanson; H C Kraemer; S P Hinshaw; L E Arnold; C K Conners; H B Abikoff; W Clevenger; M Davies; G R Elliott; L L Greenhill; L Hechtman; B Hoza; P S Jensen; J S March; J H Newcorn; E B Owens; W E Pelham; E Schiller; J B Severe; S Simpson; B Vitiello; K Wells; T Wigal; M Wu
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2001-02       Impact factor: 8.829

Review 9.  Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder.

Authors:  Steven Pliszka
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2007-07       Impact factor: 8.829

Review 10.  Drug-induced bladder and urinary disorders. Incidence, prevention and management.

Authors:  M J Drake; P M Nixon; J P Crew
Journal:  Drug Saf       Date:  1998-07       Impact factor: 5.606
View more
  1 in total

Review 1.  Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.

Authors:  Ole Jakob Storebø; Nadia Pedersen; Erica Ramstad; Maja Lærke Kielsholm; Signe Sofie Nielsen; Helle B Krogh; Carlos R Moreira-Maia; Frederik L Magnusson; Mathilde Holmskov; Trine Gerner; Maria Skoog; Susanne Rosendal; Camilla Groth; Donna Gillies; Kirsten Buch Rasmussen; Dorothy Gauci; Morris Zwi; Richard Kirubakaran; Sasja J Håkonsen; Lise Aagaard; Erik Simonsen; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2018-05-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.